Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta cir. bras ; 34(7): e201900704, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1038112

RESUMO

Abstract Purpose: The effects of resveratrol administration on calvarial bone defects with alloplastic graft material was investigated for osteoinductive reaction and bone development in rats. Methods: Healthy male rats were randomly divided into 3 groups consisting of 10 rats. Groups were as follows: control (defect) group, defect + graft group, and defect + graft + resveratrol group. A calvarial bone defect was created in all groups, alloplastic bone grafts were applied to the defect in the 2nd and 3rd group, resveratrol (5 mg/kg/day) was added to the drinking water of the animals following graft application for 28 days in the 3rd group. Results: Increase in osteoclasts and necrotic changes were observed histopathologically in the control group. In the 2nd group, reduction of inflammation, congestion of blood vessels, increased osteblastic activity, osteoinductive effect, progression of osteocyte development and increased collagen fibers in connective tissue were observed. In the 3rd group, osteoblasts seemed to secrete bone matrix and accelerate osteoinductive effect with increased osteopregenitor activity and positive osteopontin and osteonectin expressions. Conclusion: Resveratrol treatment was thought to be an alternative and supportive drug for implant application by inducing new bone formation in the calvaral defect region as a result of short-term treatment.


Assuntos
Animais , Masculino , Ratos , Crânio/cirurgia , Regeneração Óssea/efeitos dos fármacos , Transplante Ósseo/métodos , Substitutos Ósseos/administração & dosagem , Resveratrol/administração & dosagem , Osteoblastos/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Crânio/efeitos dos fármacos , Esquema de Medicação , Osteonectina/administração & dosagem , Osseointegração/efeitos dos fármacos , Substitutos Ósseos/uso terapêutico , Modelos Animais de Doenças , Osteopontina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA